<DOC>
	<DOCNO>NCT02171559</DOCNO>
	<brief_summary>To investigate relative bioavailability pharmacodynamics dabigatran switch enoxaparin dabigatran etexilate compare dabigatran etexilate alone</brief_summary>
	<brief_title>Relative Bioavailability Pharmacodynamics Dabigatran With Enoxaparin Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>1 . Subjects healthy male female base upon complete medical history , include physical examination , vital sign ( blood pressure , pulse rate ) , 12lead ECG , clinical laboratory test 2 . Age ≥18 ≤55 year 3 . Body mass index ( BMI ) ≥18.5 ≤29.9 kg/m2 4 . Signed date write informed consent prior admission study accordance GCP local legislation 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological , hormonal disorder 2 . Relevant surgery gastrointestinal tract 3 . History bleed disorder acute blood coagulation defect 4 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 5 . History relevant orthostatic hypotension , faint spell blackouts 6 . Chronic relevant acute infection 7 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 8 . Intake medication within 2 week first dose , especially intake medication , influence blood clotting , i.e . acetylsalicylic acid , cumarin etc . 9 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 4 week prior administration trial 10 . Alcohol abuse ( 60 g/day male 20 g/day female ) 11 . Drug abuse 12 . Intake grapefruit , grapefruit juice , product contain grapefruit juice , Seville oranges , garlic supplement , St. John 's wort within 5 day first dose 13 . Participation another trial investigational drug within 2 month prior trial drug administration trial 14 . Blood donation ( 100 mL within 4 week prior trial drug administration trial ) 15 . Excessive physical activity ( within 1 week prior trial drug administration trial ) 16 . Any laboratory value outside reference range clinical relevance 17 . Inability comply dietary regimen study centre 18 . Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) 19 . Inability refrain smoke trial day For female subject : 20 . Pregnancy / positive pregnancy test , plan become pregnant study within 1 month study completion 21 . No adequate contraception study within 1 month study completion implant , injectables , combine oral contraceptive , intrauterine device , sexual abstinence ( least 1 month prior enrolment ) , vasectomised partner ( vasectomy perform least 1 year prior enrolment ) , surgical sterilisation ( include hysterectomy ) . Females , vasectomise partner , sexually abstinent surgically sterile , ask additionally use barrier contraception method ( e.g . condom , diaphragm spermicide ) 22 . Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>